Overview

A Study for Patients With Active Rheumatoid Arthritis Despite Ongoing Methotrexate Therapy

Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
To assess the efficacy of LY2127399 versus placebo using American College of Rheumatology (ACR)50 response scale at 24 weeks
Phase:
Phase 2
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Antibodies, Monoclonal
Methotrexate